Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Liozon

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Journal of Clinical Medicine|December 23, 2022
Immune-Mediated Diseases Following COVID-19 Vaccination: Report of a Teaching Hospital-Based Case-SeriesEric Liozon, Matthieu Filloux, Simon Parreau, et al.
Clinical Rheumatology|August 1, 2018
Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control studyHubert de Boysson, Eric Liozon, Kim Heang Ly, et al.
Rheumatology International|April 6, 2023
New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control studyEric Liozon, Simon Parreau, Stéphanie Dumonteil, et al.
The Journal of Rheumatology|May 3, 2016
Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 PatientsEric Liozon, François Dalmay, Fabrice Lalloue, et al.
Mediators of Inflammation|May 31, 2003
No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritisYves Denizot, Eric Liozon, Laurence Guglielmi, et al.
The Journal of Rheumatology|March 17, 2018
Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control StudyEric Liozon, Hubert de Boysson, François Dalmay, et al.
Journal of the American Geriatrics Society|May 20, 2003
Visual prognosis in extremely old patients with temporal (giant cell) arteritisEric Liozon, Véronique Loustaud-Ratti, Kim Ly, et al.
The American Journal of Medicine|November 13, 2002
Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infectionVéronique Loustaud-Ratti, Eric Liozon, Hussein Karaaslan, et al.
Journal of the American Geriatrics Society|May 6, 2008
Prognosis of acquired hemophilia in older peopleStéphane Girault, Kim Ly, Arnaud Jaccard, et al.
The Journal of Rheumatology|October 15, 2023
Frequency and Significance of Hepatic Involvement in New-Onset Giant Cell Arteritis: A Study of 514 PatientsSimon Parreau, Stéphanie Dumonteil, Guillaume Gondran, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|December 23, 2022
Immune-Mediated Diseases Following COVID-19 Vaccination: Report of a Teaching Hospital-Based Case-SeriesEric Liozon, Matthieu Filloux, Simon Parreau, et al.
Clinical Rheumatology|August 1, 2018
Giant cell arteritis presenting as isolated inflammatory response and/or fever of unknown origin: a case-control studyHubert de Boysson, Eric Liozon, Kim Heang Ly, et al.
Rheumatology International|April 6, 2023
New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case-control studyEric Liozon, Simon Parreau, Stéphanie Dumonteil, et al.
The Journal of Rheumatology|May 3, 2016
Risk Factors for Permanent Visual Loss in Biopsy-proven Giant Cell Arteritis: A Study of 339 PatientsEric Liozon, François Dalmay, Fabrice Lalloue, et al.
Mediators of Inflammation|May 31, 2003
No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritisYves Denizot, Eric Liozon, Laurence Guglielmi, et al.
The Journal of Rheumatology|March 17, 2018
Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control StudyEric Liozon, Hubert de Boysson, François Dalmay, et al.
Journal of the American Geriatrics Society|May 20, 2003
Visual prognosis in extremely old patients with temporal (giant cell) arteritisEric Liozon, Véronique Loustaud-Ratti, Kim Ly, et al.
The American Journal of Medicine|November 13, 2002
Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infectionVéronique Loustaud-Ratti, Eric Liozon, Hussein Karaaslan, et al.
Journal of the American Geriatrics Society|May 6, 2008
Prognosis of acquired hemophilia in older peopleStéphane Girault, Kim Ly, Arnaud Jaccard, et al.
The Journal of Rheumatology|October 15, 2023
Frequency and Significance of Hepatic Involvement in New-Onset Giant Cell Arteritis: A Study of 514 PatientsSimon Parreau, Stéphanie Dumonteil, Guillaume Gondran, et al.
Pageof 9